Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00624650 · ClinicalTrials.gov registry record · Phase 2
Hemodynamics and Extravascular Lung Water in Acute Lung Injury
A Phase 2 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 2
- Development phase
- 33
- Enrollment target
NCT00624650 is a Phase 2 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 33 participants.
The verdict
NCT00624650, a Phase 2 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to test a treatment that tries to reduce the amount of fluid in the lungs of subjects with acute lung injury to see if this is helpful.
Interventions
- DRUG Diuresis (furosemide) part I
- OTHER Fluid Bolus (crystalloid or albumin)
- DRUG Vasopressors (Norepinephrine, Vasopressin, Phenylephrine, Epinephrine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2008-02 |
| Est. Completion | 2011-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00624650
The ClinicalTrials.gov registry entry for NCT00624650 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Diuresis (furosemide) part I is the first listed.
NCT00624650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00624650 about?
NCT00624650 is a clinical study titled "Hemodynamics and Extravascular Lung Water in Acute Lung Injury". The purpose of this study is to test a treatment that tries to reduce the amount of fluid in the lungs of subjects with acute lung injury to see if this is helpful.
What is the current status of trial NCT00624650?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 33 participants. The study started on 2008-02. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00624650?
The interventions under investigation include: Diuresis (furosemide) part I (DRUG), Fluid Bolus (crystalloid or albumin) (OTHER), Vasopressors (Norepinephrine, Vasopressin, Phenylephrine, Epinephrine) (DRUG).
Who is sponsoring clinical trial NCT00624650?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.